The global Assisted Reproductive Technology market size is expected to be worth around US$ 55 billion by 2030, according to a new report by Vision Research Reports.
The global Assisted Reproductive Technology market size was valued at US$ 31 billion in 2020 and is anticipated to grow at a CAGR of 20% during forecast period 2021 to 2030.
Growth Factors
Childbearing postponement is one of the high impact rendering drivers of the infertility treatment market. The reproductive behavior and pattern of some of the nations such as few European nations have shifted from early to the late childbearing pattern.
Increasing marital age, rising tobacco and alcohol consumption, increasing obesity rate are some of the other factors contributing to market growth. Furthermore, increasing incidence rate of conditions such as poly-cystic ovarian syndrome (PCOS), tubal factors, and endometriosis are other drivers of the market.
According to the Society for Assisted Reproductive Technology, 2012 was the year with the highest percentage of babies born through IVF treatment. The treatment has become more successful and has gained more acceptance, which is further expected to increase the market size in the coming years.
Report Highlights
ART market, by procedure, is categorized into frozen non-donor, frozen donor, fresh non-donor, and fresh donor. Fresh non-donor held the largest revenue share in 2017. However, frozen non-donor is expected to witness lucrative growth over the forecast period. According to 2010 and 2012 data by the CDC, in the U.S., out of the different cycles available, fresh non-donor led the market with the maximum number of cycles performed that year. IVF with ICSI was most widely used in case of fresh non-donor eggs or embryos followed by IVF without ICSI.
According to 2003-2012 trends by the CDC, the number of fresh nondonors banking the eggs/embryos for future use has been increased considerably. The frozen method has an advantage over fresh methods as it is less expensive and the recipient does not have to go through the drug stimulation process and is less invasive. Many reimbursement policies have also encouraged more people to donate or store their gametes. Also, Medical Egg Freezing (MEF) is recommended for women at risk of losing fertility owing to cancer treatment and other fertility threatening diseases.
Where other centers offer risk sharing plans and refund only for 3 cycles, the advanced fertility center of Chicago has designed the IVF refund plan where it allows 100% refund up to 4 cycles with fresh embryos. Moreover, giant players such as Apple and Facebook have started offering perks to women employees to store their sperms to decrease the attrition rate. This will help career-oriented women to maintain a work-life balance.
On the basis of technology, the market is segmented into In-vitro fertilization (IVF), and others including Gamete Intrafallopian Transfer (GIFT) and Zygote Intrafallopian Transfer (ZIFT). Further, IVF is sub-segmented into IVF with Intracytoplasmic Sperm Injection (ICSI) and IVF without ICSI.
In-vitro fertilization dominated the market in 2017. Favorable reimbursement policies and the introduction of new technology are some factors contributing to market growth. For instance, in June 2015, Adelaide University in Australia came up with BlastGen technology. Though this technology was under clinical trials it had presented convincing results and its commercialization is expected to increase the success rate in women who had failed IVF treatment.
Standardization of procedures through automation, regulatory reforms, and government funding for egg/sperm storage are some of the contributing factors of the IVF market. The government provides funds for experiments, which can help patients with better success rates and economic costs. For instance, the Toronto Centre for Advanced Reproductive Technology (TCART) was the first Canadian Clinic to provide free IVF to 60 women to experiment with the AUGMENT rejuvenating technique. The technique allowed older cells to rejuvenate by taking smaller cells from the outer ovary lining. This process allowed the harvesting of young cells and higher treatment success rates.
Europe dominated the market in 2017 due to a rise in infertility rate, rising awareness among people for fertility treatment, technological advancements, and government initiatives. In June 2014, CDC developed a national public health action plan for detection, improved efficacy of safe treatment, and prevention of infertility. The Barcelona summit suggested the establishment of an expert group to solve demographic issues, increase the childcare facilities, and acceptance of parent IVF procedure for clinical trials. Spain and Italy are other countries with a wide acceptance of assisted reproductive technology procedures. As per update of 2017, a lesbian couple and single women in France are expected to have access to the ART in the coming years
North America is also expected to witness growth in the coming years. This is due to people's awareness about various fertility options, government support for the in-vitro fertilization, and various technological and procedure up-gradation. For instance, in August 2015 Ovascience’s treatment named AUGMENT has been reported to have rejuvenated women’s aging egg cells and provided benefits to eggs with poor quality. In February 2015, the scientist of U.S. who invented the three-parent IVF procedure requested the Food and Drug Administration (FDA) to grant permission for its clinical trials as age-related infertility
Asia Pacific is expected to be the fastest-growing market in the coming years. The drivers for Asia Pacific region are late family planning and comparatively lower treatment cost. Asia Pacific Initiative on Reproduction (ASPIRE), held on 4th April 2014, was to provide guidance to the healthcare professionals on how to assist the patients on various infertility treatments and to increase the quality of patient care.
Key Players
California Cryobank, Bloom IVF Centre, Parallabs, OvaScience, Anecova, Origio, Microm Ltd., Merck KGaA, Cooper Surgical, Inc, Ferring Pharmaceuticals, Irvine Scientific and Hamilton Throne Ltd. Continuous technological advancements,
Market Segmentation
Procedure Outlook
Fresh Donor
Fresh Nondonor
Frozen Donor
Frozen Nondonor
Embryo/Egg Banking
Type Outlook
IVF
IVF with ICSI
IVF without ICSI
Others
End-use Outlook
Hospital
Fertility Clinics
Regional Outlook
North America
The U.S.
Canada
Europe
The U.K.
Germany
France
Asia Pacific
Japan
China
India
Latin America
Brazil
Mexico
Middle East & Africa
South Africa
The Assisted Reproductive Technology market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Assisted Reproductive Technology market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Assisted Reproductive Technology market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Assisted Reproductive Technology market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Assisted Reproductive Technology market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Assisted Reproductive Technology capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Assisted Reproductive Technology by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Assisted Reproductive Technology market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Assisted Reproductive Technology market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Assisted Reproductive Technology market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Assisted Reproductive Technology industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Assisted Reproductive Technology market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Assisted Reproductive Technology market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Assisted Reproductive Technology market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Assisted Reproductive Technology market. These factors have benefited the growth of the global market for Assisted Reproductive Technology. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Assisted Reproductive Technology. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Assisted Reproductive Technology are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers